A recent study published in JAMA Otolaryngology has uncovered a concerning link between the consumption of sugar-sweetened beverages (SSBs) and an increased risk of oral cavity cancer in women, including both smokers and non-smokers. The findings show that women who regularly consumed sugary drinks were found to have a significantly higher risk of developing oral cavity cancers compared to those who consumed them less frequently.
The AI-powered prostate cancer test developed by EDX Medical Group represents a major advancement in early detection. By analysing over 100 biological markers in blood and urine samples, it offers a more accurate assessment of prostate cancer risk than traditional methods like PSA testing, highlighting the critical role of early detection in improving patient outcomes.
We are witnessing a crucial moment for the NHS as it promises to reduce waiting lists and deliver timely care. This commitment resonates with patients and healthcare professionals. However, while the intentions behind these proposals are laudable, critical questions remain regarding their feasibility, workforce capacity, and long-term sustainability by the NHS.
Olympic cyclist Sir Chris Hoy is advocating for improved prostate cancer tests for younger men following his terminal diagnosis in September 2023. His recent interview with the BBC reveals the limitations of the NHS’s current protocol for prostate cancer testing.
In a recent press release, the UK government outlined an initiative to boost tech deals aimed at further innovating cancer diagnosis in the country.
This plan follows the Darzi review, which highlighted the critical state of the NHS, particularly the urgent need to improve cancer survival rates.
In the House of Commons, Health Secretary Wes Streeting introduced a “national mission” to tackle key health challenges. Presenting the Darzi report, commissioned by the Labour government, he outlined the NHS’s ongoing struggles in the post-pandemic era, including missed targets in cancer care, A&E services, and hospital treatment.
Last month, the UK National Screening Committee (UK NSC) shared their updated view on Multi-Cancer Detection (MCD) tests. They highlighted the potential and the immediate need for a multi-cancer detection solution in the UK. They are working to outline a roadmap for...
Historically, early detection has focused on routine screenings for only a handful of cancers, such as breast, colorectal, cervical, lung, and prostate cancers. However, these screenings are not always effective. Many cancers are still detected at later stages when...
Last month the BBC revealed that “cancer waiting times for 2023 in England were the worst on record”. Only 64.1% of patients started treatment within 62 days of a cancer suspicion, meaning nearly 100,000 waited longer than they should for life-saving care. These...
Cancer is a major global health concern, but it’s typically associated with older age. However, in recent years, there has been a clear rise in younger individuals who have early-onset cancer. In this article, we will break down the findings of a study conducted in...